In his battle with acute myeloid leukemia, Todrick is grateful for the care he receives from the physicians, nurses and staff at Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System.
“They’re the specialists,” he said. “Just knowing you’re in good hands is a good feeling.”
A bone marrow transplant was required after Todrick was diagnosed with the potentially fatal blood disorder.
“There’s no way you can prepare for it, to hear that diagnosis,” he said.
After chemotherapy treatments, Todrick benefited from haploidentical transplantation, a new process that does not require a complete donor match. It enabled his father to be his donor.
Todrick’s Continuing Care
Approximately nine months post-transplantation, Todrick suffered a relapse and the Moffitt-Memorial team continues to help him fight his aggressive leukemia, using ongoing chemotherapy, as well as stem cells from his father to control the disease.
“I always try to give patients hope,” said Hugo Fernandez, MD, Chair and Medical Director, Moffitt Malignant Hematology & Cellular Therapy at Memorial. “And I’m going to be there for them to get through this.”